Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Woosol Chris Hong"'
Autor:
Myeong Jin Kim, Hyung Sun Kim, Hyeon Woong Kang, Da Eun Lee, Woosol Chris Hong, Ju Hyun Kim, Minsoo Kim, Jae-Ho Cheong, Hyo Jung Kim, Joon Seong Park
Publikováno v:
Cells, Vol 12, Iss 20, p 2509 (2023)
Pancreatic cancer is characterized by a poor prognosis, with its five-year survival rate lower than that of any other cancer type. Gemcitabine, a standard treatment for pancreatic cancer, often has poor outcomes for patients as a result of chemoresis
Externí odkaz:
https://doaj.org/article/15f724e6ef664ac89b265611ea655c11
Autor:
Woosol Chris Hong, Da Eun Lee, Hyeon Woong Kang, Myeong Jin Kim, Minsoo Kim, Ju Hyun Kim, Sungsoon Fang, Hyo Jung Kim, Joon Seong Park
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 16, p 12993 (2023)
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive form of pancreatic cancer with a poor prognosis and low survival rates. The prognostic and predictive biomarkers of PDAC are still largely unknown. The receptor CD74 was recently identified as
Externí odkaz:
https://doaj.org/article/5873c83463a04025a748c50b47545fb7
Autor:
Da Eun Lee, Hyeon Woong Kang, So Yi Kim, Myeong Jin Kim, Jae Woong Jeong, Woosol Chris Hong, Sungsoon Fang, Hyung Sun Kim, Yun Sun Lee, Hyo Jung Kim, Joon Seong Park
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Pancreatic cancer is an aggressive cancer characterized by high mortality and poor prognosis, with a survival rate of less than 5 years in advanced stages. Ivermectin, an antiparasitic drug, exerts antitumor effects in various cancer types. This is t
Externí odkaz:
https://doaj.org/article/d1b46252660d49c892f1281933ffbb3b
Autor:
Yun Sun Lee, Hyung Sun Kim, HYO JUNG KIM, Hyeon Woong Kang, Da Eun Lee, Myeong Jin Kim, Woosol Chris Hong, Ju Hyun Kim, Minsoo Kim, Joon Seong Park
Gemcitabine is considered a standard treatment for pancreatic cancer, but developing drug resistance greatly limits the effectiveness of chemotherapy and increases the rate of recurrence. Lysyl oxide-like 2 (LOXL2) is highly expressed in pancreatic c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::249618abdfe528777a886d1f0384ca40
https://doi.org/10.21203/rs.3.rs-2699030/v1
https://doi.org/10.21203/rs.3.rs-2699030/v1
Autor:
Yun Sun Lee, Hyung Sun Kim, Hyo Jung Kim, Hyeon Woong Kang, Da Eun Lee, Myeong Jin Kim, Woosol Chris Hong, Ju Hyun Kim, Minsoo Kim, Joon Seong Park
Purpose Gemcitabine is considered a standard treatment for pancreatic cancer, but developing drug resistance greatly limits the effectiveness of chemotherapy and increases the rate of recurrence. Lysyl oxide-like 2 (LOXL2) is highly expressed in panc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb4844cbd492e13f70feedab32f2da8b
https://doi.org/10.21203/rs.3.rs-2261076/v1
https://doi.org/10.21203/rs.3.rs-2261076/v1